Clinical Trial Equipment and Ancillary Solutions Market Report 2026

The clinical trial equipment and ancillary solutions market size has grown strongly in recent years. It will grow from $2.77 billion in 2025 to $3.02 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increasing number of global clinical trials, expansion of pharmaceutical research activities, rising outsourcing to contract research organizations, growth in medical device trials, availability of standardized clinical trial equipment.

The clinical trial equipment and ancillary solutions market size is expected to see strong growth in the next few years. It will grow to $4.09 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing adoption of decentralized and hybrid trials, rising demand for real-time trial data monitoring, expansion of digital health technologies in trials, growing focus on patient-centric trial designs, increasing regulatory complexity in clinical research. Major trends in the forecast period include increasing adoption of integrated clinical trial management systems, rising use of digital and remote trial equipment, growing demand for ancillary logistics and support services, expansion of decentralized clinical trial solutions, enhanced focus on regulatory-compliant trial infrastructure.

The increasing prevalence of chronic diseases is expected to drive the growth of the clinical trial equipment and ancillary solutions market in the coming years. Chronic diseases are long-term conditions that typically require continuous medical care and can restrict daily activities or reduce quality of life. The rising burden of chronic diseases is associated with factors such as exposure to air pollution, chemicals and toxins, lifestyle changes, and genetic influences. Clinical trial equipment and ancillary solutions play a critical role in improving outcomes for patients with chronic conditions by supporting early disease detection, personalized treatment strategies, objective evaluation of treatment effectiveness, safety monitoring, patient engagement, optimized trial design, regulatory compliance, and collaborative research efforts. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal agency, approximately 194 million adults in the United States, or 76.4%, reported having at least one chronic condition in 2023. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93% among older adults. Therefore, the growing prevalence of chronic diseases is contributing to the expansion of the clinical trial equipment and ancillary solutions market.

Rising healthcare expenditure is also expected to propel the growth of the clinical trial equipment and ancillary solutions market going forward. Healthcare expenditure represents the total financial resources allocated by individuals, organizations, or governments toward the prevention, treatment, and management of health conditions. Spending on healthcare continues to increase due to advancements in medical technology, as innovative diagnostic tools, therapies, and treatments often involve higher costs. Higher healthcare expenditure supports the demand for clinical trial equipment and ancillary solutions by enabling increased clinical research activity, adoption of advanced technologies, adherence to regulatory standards, and expansion into a broader range of therapeutic areas. For example, in December 2024, according to the Centers for Medicare and Medicaid Services, a US-based agency overseeing Medicare and Medicaid programs, healthcare spending in the United States rose by 7.5% in 2023, reaching $4.9 trillion, or approximately $14,570 per person. As a result, rising healthcare expenditure is driving growth in the clinical trial equipment and ancillary solutions market.

In March 2024, Myonex, a US-based pharmaceutical company, acquired Creapharm Group for an undisclosed amount. Through this acquisition, Myonex seeks to strengthen its pharmaceutical services portfolio by integrating Creapharm’s clinical packaging, distribution, and bio services. This integration enables Myonex to offer more flexible and reliable solutions to pharmaceutical and biotechnology companies across both clinical and commercial stages, including those involved in advanced therapies. Creapharm is a France-based pharmaceutical technology company that provides clinical trial equipment and ancillary solutions.

Major companies operating in the clinical trial equipment and ancillary solutions market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., Iron Mountain Incorporated (IRM), PerkinElmer Inc., Illumina Inc., Sartorius AG, PAREXEL International Corp., Marken, Shimadzu Corporation, Waters Corporation, Bruker Corporation, Eppendorf AG, Tecan Group AG, Mettler Toledo International Inc., Hamilton Company, Repligen Corporation, Labconco Corporation, Ancillare LP, Binder GmbH, Germfree Laboratories Inc., Nuaire Inc., Sheldon Manufacturing Inc., Esco Micro Pte. Ltd.

North America was the largest region in the clinical trial equipment and ancillary solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial equipment and ancillary solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical trial equipment and ancillary solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the clinical trial equipment and ancillary solutions market by increasing costs of imported diagnostic devices, laboratory instruments, monitoring equipment, temperature-controlled systems, and software infrastructure. Pharmaceutical companies and CROs in North America and Europe are most affected due to dependence on imported trial equipment, while Asia-Pacific faces cost pressures in expanding trial infrastructure. These tariffs are raising trial setup costs and extending timelines. However, they are also promoting domestic equipment sourcing, regional service providers, and localized development of clinical trial support solutions.

The clinical trial equipment and ancillary solutions market research report is one of a series of new reports that provides clinical trial equipment and ancillary solutions market statistics, including clinical trial equipment and ancillary solutions industry global market size, regional shares, competitors with a clinical trial equipment and ancillary solutions market share, detailed clinical trial equipment and ancillary solutions market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trial equipment and ancillary solutions industry. This clinical trial equipment and ancillary solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Clinical trial equipment and ancillary solutions encompass a wide range of products, services, and support systems used in clinical research to support the planning, execution, and management of clinical trials. These solutions are essential for conducting safe, efficient, and compliant clinical studies across various therapeutic areas and stages of drug development. Clinical trial equipment and ancillary solutions play a key role in ensuring the successful planning, execution, and completion of clinical trials, thereby contributing to advances in medical research and improved patient care.

The primary types of clinical trial equipment and ancillary solutions include diagnostic equipment, laboratory instruments, and ancillary solutions. Diagnostic equipment consists of specialized devices used in clinical trials to detect, diagnose, or monitor health conditions or assess the effects of investigational treatments. Associated services include rental and leasing services, supply and logistics services, regulatory compliance services, and software services. These solutions are utilized by a range of end users, including pharmaceutical and biotechnology companies, contract research organizations, medical device companies, and others.

The clinical trial equipment and ancillary solutions market consists of revenues earned by entities by providing services such as clinical trial supply services, laboratory services, data management and technology solutions, regulatory and compliance services, and training and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial equipment and ancillary solutions market also includes sales of auditing tools, inventory management tools, and safety signal detection tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.